Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03540030 · ClinicalTrials.gov registry record · Phase 4

Opioid-Free Shoulder Arthroplasty

A Phase 4 study of Opioid Use and Avascular Necrosis, sponsored by OrthoCarolina Research Institute.

Completed
Registry status
Phase 4
Development phase
86
Enrollment target
1
Study location

NCT03540030: Completed Phase 4 study of Opioid Use and Avascular Necrosis, sponsored by OrthoCarolina Research Institute.

NCT03540030 is a Phase 4 study of Opioid Use and Avascular Necrosis that has completed, run by OrthoCarolina Research Institute. The registered enrollment target is 86 participants, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03540030, a Phase 4 study of Opioid Use and Avascular Necrosis, has completed, sponsored by OrthoCarolina Research Institute.

COMPLETED
Registry status
Phase 4
Development phase
86 participants
Enrollment target
1
Study location

Study Summary

Purpose of Study: To identify and provide a safe, opioid-free treatment pathway for shoulder arthroplasty with a focus on perioperative pain control and postoperative symptoms from treatment

Primary Outcome

Pain at patient discharge or 24-hours, whichever comes first - measured on a 0 (no pain) -10 (worst possible pain) numeric rating scale (NRS). A score of 0(no pain) is preferable to 10(worst possible pain)

Conditions Studied

Opioid Use Avascular Necrosis Rotator Cuff Tear Shoulder Osteoarthritis Arthritis;Inflammatory

Interventions

  • DRUG Celecoxib
  • DRUG Gabapentin
  • DRUG acetaminophen
  • DRUG toradol
  • DRUG regional block

Study Locations (1)

North Carolina

  • OrthoCarolina Research Institute - Charlotte

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2016-09
Est. Completion 2019-06
Phase Phase 4
OrthoCarolina Research Institute

28 total trials

What the finished NCT03540030 record still lists

NCT03540030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).

The record links to 5 conditions, with Opioid Use appearing as the primary indexed condition, and to 5 interventions - of which Celecoxib is the first listed.

NCT03540030 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03540030 about?

NCT03540030 is a clinical study titled "Opioid-Free Shoulder Arthroplasty". Purpose of Study: To identify and provide a safe, opioid-free treatment pathway for shoulder arthroplasty with a focus on perioperative pain control and postoperative symptoms from treatment

What is the current status of trial NCT03540030?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 86 participants. The study started on 2016-09. Estimated completion is 2019-06.

What conditions does trial NCT03540030 study?

This clinical trial studies the following conditions: Opioid Use, Avascular Necrosis, Rotator Cuff Tear, Shoulder Osteoarthritis, Arthritis;Inflammatory.

What interventions are being tested in trial NCT03540030?

The interventions under investigation include: Celecoxib (DRUG), Gabapentin (DRUG), acetaminophen (DRUG), toradol (DRUG), regional block (DRUG).

Who is sponsoring clinical trial NCT03540030?

This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03540030 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03540030's enrollment target sits among peer trials

86 73rd of 105 higher than 33 of 105 other Opioid Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01639508 · 86 participants · Phase 2

    Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

  • NCT03519269 · 86 participants · NA

    Navio Robotic Versus Conventional Total Knee Arthroplasty

  • NCT04132999 · 86 participants · NA

    PAP for Children With DS and OSAS

  • NCT04545957 · 86 participants · NA

    Jump: MR Simulation For Radiation Therapy Master Protocol

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT03540030, the US trial registry maintained by the National Library of Medicine. NCT03540030 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.